WSAVA Announces Zoetis As New Partner Supporting Efforts To Improve Global Pain Management
Animal health company Zoetis has joined with the World Small Animal Veterinary Association to support its Global Pain Council, a specialist group of global veterinarians with expertise in companion animal pain management.
Effective pain management is fundamental in veterinary practice. The Global Pain Council works to address global variations in the assessment and management of animal pain by providing education and advisory resources. The Global Pain Council also strives to increase the confidence and competence of veterinary professionals worldwide in companion animal pain management through initiatives such as the recently launched ‘teach the teacher’ training program and its Global Pain Guidelines, WSAVA’s most frequently accessed veterinary resource.
Zoetis, a long-time supporter of WSAVA’s annual flagship World Congress, discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products. Commenting on its partnership with WSAVA and the Global Pain Council, Abhay Nayak, Sr. Vice President and head of corporate strategy, commercial development, and customer experience, said: “Zoetis is committed to supporting veterinarians in helping improve the lives of dogs and cats living with pain. We are excited to partner with leaders at WSAVA and the Global Pain Council to extend our reach in providing education and resources to veterinarians worldwide to benefit more pets.”
Dr Shane Ryan, WSAVA President, said: “Managing our patients’ pain is one of the most important things we do as veterinarians. Variations in the provision of effective pain management globally are a serious concern and the Global Pain Council, through its Global Pain Guidelines and other resources, is already providing enormous animal health and welfare benefits. Now, with the support of Zoetis, the GPC will be able to achieve even more. We are very pleased and appreciate the company’s commitment.”
The WSAVA represents more than 200,000 veterinarians worldwide through its 113 member associations and works to enhance standards of clinical care for companion animals. Its core activities include the development of WSAVA Global Guidelines in key areas of veterinary practice, including pain management, nutrition and vaccination, together with lobbying on important issues affecting companion animal care worldwide.
Notes to editors:
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees. For more information, visit www.zoetis.com.
For further information, please contact:
Rebecca George, George PR
Tel: +44 1449 737281/+44 7974 161108
More from WSAVA
- Thai Veterinarian Dr Siraya Chunekamrai Elected WSAVA President
- WSAVA/FECAVA Congress Goes Hybrid for 2020 to Increase Access to the Learning on Offer
- 'No new evidence of transmission from a dog, cat, or ferret to a new human' says WSAVA
- WSAVA webinars to highlight the work of key stakeholders to prioritize welfare on World Rabies Day
- WSAVA Webinar: The Impact of COVID-19 on your Patients and Staff